V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013276 | 160017640 | 1.85 | 64 | Palliative (P) | 2020-06-22 | 2020-07-01 | Trabectedin | 02 | N | TRABECTEDIN | 101588323 |
| 160013281 | 160017641 | 1.75 | 17.2 | Palliative (P) | 2020-08-02 | 2020-08-05 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100472229 |
| 160013285 | 160017642 | 1.63 | 89 | Palliative (P) | null | 2019-09-06 | Trabectedin | 02 | null | TRABECTEDIN | 101219911 |
| 160013301 | 160017643 | 1.57 | 60.4 | Palliative (P) | null | 2019-04-09 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101445911 |
| 160013316 | 160017644 | 1.72 | 80.6 | Palliative (P) | 2018-09-28 | 2018-10-06 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101205907 |
| 160013318 | 160017645 | 1.67 | 72.3 | Palliative (P) | 2020-06-07 | 2020-06-13 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100555808 |
| 160013332 | 160017646 | 1.73 | 88 | Palliative (P) | 2020-11-26 | 2020-12-28 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100642119 |
| 160013340 | 160017647 | 1.54 | 56.6 | Palliative (P) | 2021-03-18 | 2021-03-27 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 100897656 |
| 160013344 | 160017648 | 1.65 | 71.7 | null | 2020-12-08 | 2020-12-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101474184 |
| 160013345 | 160017649 | 1.57 | 85.9 | null | 2020-12-23 | 2020-12-26 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100698434 |
| 160013359 | 160017650 | 1.77 | 74 | Palliative (P) | 2021-02-25 | 2021-03-04 | VINORELBINE | 2 | N | VINORELBINE | 101005052 |
| 160013372 | 160017651 | 1.54 | 68.5 | Palliative (P) | 2021-09-15 | 2021-09-15 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101726089 |
| 160013374 | 160017652 | 1.6 | 66.4 | Palliative (P) | null | null | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100159492 |
| 160013375 | 160017653 | 1.65 | 77.6 | null | 2017-09-23 | 2017-09-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101181422 |
| 160013379 | 160017654 | 1.81 | 94.4 | Palliative (P) | 2021-10-12 | 2021-10-16 | Trabectedin | 02 | N | TRABECTEDIN | 100401618 |
| 160013391 | 160017655 | 1.73 | 67.8 | Palliative (P) | 2017-08-30 | 2017-08-31 | Vinorelbine (weekly iv) | 02 | N | VINORELBINE | 100657827 |
| 160013394 | 160017656 | 1.72 | 86.8 | Palliative (P) | 2017-11-22 | 2017-11-24 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100193155 |
| 160013402 | 160017657 | 1.73 | 82 | null | 2016-12-01 | 2017-03-22 | NIVOLUMAB | 02 | null | TRABECTEDIN | 101472333 |
| 160013408 | 160017658 | 1.73 | 55.2 | Palliative (P) | 2022-02-03 | 2022-02-05 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101393182 |
| 160013409 | 160017659 | 1.57 | 108.35 | null | 2019-07-17 | 2019-08-26 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 100716809 |
| 160013414 | 160017660 | 1.82 | 73.35 | Palliative (P) | 2018-12-12 | 2018-12-12 | DOXORUBICIN | 02 | N | TRABECTEDIN | 100000701 |
| 160013422 | 160017661 | 1.77 | 86.7 | Palliative (P) | 2020-10-12 | 2020-10-12 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100232852 |
| 160013444 | 160017662 | 1.49 | 51.1 | Palliative (P) | 2020-02-10 | 2020-02-19 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101333690 |
| 160013453 | 160017663 | 1.67 | 76 | Palliative (P) | 2021-05-30 | 2021-06-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100513473 |
| 160013471 | 160017664 | 1.85 | 87.85 | Palliative (P) | 2021-06-28 | 2021-07-30 | DOXORUBICIN | 02 | N | NIVOLUMAB | 101145327 |
| 160013477 | 160017666 | 1.91 | 86 | Palliative (P) | 2018-12-12 | 2018-12-19 | Trabectedin | 02 | N | NIVOLUMAB | 100846649 |
| 160013510 | 160017667 | 1.75 | 87 | Palliative (P) | 2017-10-26 | 2017-11-03 | VINORELBINE | null | N | VINORELBINE | 100676438 |
| 160013522 | 160017668 | 1.72 | 106 | null | 2021-03-15 | 2021-04-19 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101062105 |
| 160013534 | 160017669 | 1.8 | 79.8 | Palliative (P) | 2017-06-12 | 2017-10-13 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101401548 |
| 160013540 | 160017670 | 1.73 | 65.9 | null | null | 2019-10-23 | Bevacizumab | null | null | PACLITAXEL | 100878532 |
| 160013549 | 160017671 | 1.78 | 84.9 | Palliative (P) | 2017-06-25 | 2017-07-12 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100745459 |
| 160013573 | 160017672 | 1.66 | 76 | 03 | null | 2019-04-28 | Bevacizumab 7.5mg/kg | N | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100664893 |
| 160013577 | 160017673 | 1.91 | 67.7 | Neo-adjuvant (N) | 2020-11-07 | 2020-11-21 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 100577065 |
| 160013579 | 160017674 | 1.76 | 63.35 | Palliative (P) | 2018-04-04 | 2018-04-05 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101564724 |
| 160013581 | 160017675 | 1.75 | 40 | Palliative (P) | 2019-08-07 | 2019-08-08 | Bevacizumab | null | null | BEVACIZUMAB | 101684169 |
| 160013592 | 160017676 | 1.88 | 62.8 | Palliative (P) | 2020-07-31 | 2020-08-08 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 101039644 |
| 160013594 | 160017677 | 1.63 | 60 | Palliative (P) | 2018-12-01 | 2019-03-20 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + GEMCITABINE | 100606212 |
| 160013605 | 160017678 | 1.8 | 89 | null | 2019-03-22 | 2019-04-07 | Liposomal Doxorubicin 50mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101211297 |
| 160013606 | 160017679 | 1.57 | 94.1 | Neo-adjuvant (N) | 2019-08-30 | 2019-09-03 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100956525 |
| 160013612 | 160017680 | 1.88 | 109.8 | Palliative (P) | 2021-01-27 | 2021-04-21 | Carboplatin AUC 2 - 5 | N | N | DOXORUBICIN + OLARATUMAB | 100317326 |
| 160013616 | 160017681 | 1.69 | 47.5 | Palliative (P) | 2020-06-29 | 2020-07-17 | Bevacizumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101318612 |
| 160013630 | 160017683 | 1.65 | 59 | Palliative (P) | 2018-02-15 | 2018-03-01 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100239657 |
| 160013636 | 160017684 | 1.75 | 42 | Palliative (P) | 2017-02-08 | 2017-02-22 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101104203 |
| 160013660 | 160017685 | 1.73 | 79.7 | Palliative (P) | 2020-04-11 | 2020-04-16 | DOCETAXEL + GEMCITABINE | 02 | N | CARBOPLATIN + PACLITAXEL | 100601404 |
| 160013666 | 160017686 | 1.5 | 52.3 | null | null | null | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101750850 |
| 160013677 | 160017687 | 1.82 | 75.15 | null | null | 2020-06-06 | Bevacizumab 7.5mg/kg | N | null | CARBOPLATIN + PACLITAXEL | 101119609 |
| 160013691 | 160017689 | 1.71 | 69 | Palliative (P) | 2017-11-22 | 2017-11-29 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101719910 |
| 160013693 | 160017690 | 1.76 | 77 | Palliative (P) | null | 2018-04-28 | Bevacizumab 15mg/kg | 02 | N | CARBOPLATIN + GEMCITABINE | 101675459 |
| 160013694 | 160017691 | 1.73 | 40 | 02 | 2018-08-27 | 2018-09-05 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100456431 |
| 160013701 | 160017692 | 1.77 | 47.6 | Palliative (P) | 2018-06-23 | 2018-07-14 | Bevacizumab 15mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101405344 |